Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hsien-Hui Chung

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|June 26, 2022
Letter to the editor: The perspective of GLP-1/GLP-2 receptors against NASH via diverse regulationHsien-Hui Chung
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2024
The liver-specific diagnosis and prognosis of fibrotic NASH through modulating fibroblast growth factor 21Hsien-Hui Chung
Hepatology (Baltimore, Md.)|January 5, 2022
Letter to the editor: The multiple mechanisms of fructose disrupt gut-liver axis and metabolic regulationHsien-Hui Chung
Hepatology (Baltimore, Md.)|March 4, 2023
Letter to the Editor: The pathological impact of PAR2 on hepatic insulin resistanceHsien-Hui Chung
Life (Basel, Switzerland)|March 28, 2026
Metabolic Concepts of Sodium-Glucose Cotransporter 2 Inhibitors-Based Therapies Against Hepatocarcinogenesis and Therapy Resistance in Hepatocellular CarcinomaHsien-Hui Chung
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 29, 2023
The metabolic evaluation of pemafibrate in nonalcoholic fatty liver disease-related cardiovascular diseasesHsien-Hui Chung
Gastroenterology|March 13, 2018
New Insights for Controversial Issues of miR-122 in Hepatic Lipid MetabolismHsien-Hui Chung
Gastroenterology|January 9, 2022
The Insightful Clarification of MicroRNA 144-Mediated Metabolic DysfunctionHsien-Hui Chung
Neuroscience Letters|August 10, 2025
The dysregulation of high glucose-induced iPSC-neural stem cells differentiation by caspase-1Hsien-Hui Chung
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 14, 2023
Integrative prediction of metabolic dysfunction-associated fatty liver disease by endogenous fructose and related metabolismHsien-Hui Chung
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|June 26, 2022
Letter to the editor: The perspective of GLP-1/GLP-2 receptors against NASH via diverse regulationHsien-Hui Chung
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2024
The liver-specific diagnosis and prognosis of fibrotic NASH through modulating fibroblast growth factor 21Hsien-Hui Chung
Hepatology (Baltimore, Md.)|January 5, 2022
Letter to the editor: The multiple mechanisms of fructose disrupt gut-liver axis and metabolic regulationHsien-Hui Chung
Hepatology (Baltimore, Md.)|March 4, 2023
Letter to the Editor: The pathological impact of PAR2 on hepatic insulin resistanceHsien-Hui Chung
Life (Basel, Switzerland)|March 28, 2026
Metabolic Concepts of Sodium-Glucose Cotransporter 2 Inhibitors-Based Therapies Against Hepatocarcinogenesis and Therapy Resistance in Hepatocellular CarcinomaHsien-Hui Chung
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 29, 2023
The metabolic evaluation of pemafibrate in nonalcoholic fatty liver disease-related cardiovascular diseasesHsien-Hui Chung
Gastroenterology|March 13, 2018
New Insights for Controversial Issues of miR-122 in Hepatic Lipid MetabolismHsien-Hui Chung
Gastroenterology|January 9, 2022
The Insightful Clarification of MicroRNA 144-Mediated Metabolic DysfunctionHsien-Hui Chung
Neuroscience Letters|August 10, 2025
The dysregulation of high glucose-induced iPSC-neural stem cells differentiation by caspase-1Hsien-Hui Chung
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 14, 2023
Integrative prediction of metabolic dysfunction-associated fatty liver disease by endogenous fructose and related metabolismHsien-Hui Chung
Pageof 5